SIBN Insider Trading

Insider Ownership Percentage: 3.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,069,631.99

SI-BONE Insider Trading History Chart

This chart shows the insider buying and selling history at SI-BONE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$130ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

SI-BONE Share Price & Price History

Current Price: $16.22
Price Change: Price Decrease of -0.37 (-2.23%)
As of 02/12/2025 05:00 PM ET

This chart shows the closing price history over time for SIBN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarAprMayJunJulAugSepOctNovDecJanFeb$16.22Closing price on 02/12/25:

SEC Filings (Institutional Ownership Changes) for SI-BONE (NASDAQ:SIBN)

98.11% of SI-BONE stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SIBN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$21Mbought$10MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50M$0$50MTotal InflowsTotal Outflows
SI-BONE logo
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Read More on SI-BONE

Today's Range

Now: $16.22
Low: $16.09
High: $16.54

50 Day Range

MA: $15.15
Low: $13.05
High: $18.10

52 Week Range

Now: $16.22
Low: $11.70
High: $21.19

Volume

305,865 shs

Average Volume

303,467 shs

Market Capitalization

$680.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Who are the company insiders with the largest holdings of SI-BONE?

SI-BONE's top insider investors include:
  1. Laura Francis (CEO)
  2. Anthony J Recupero (Insider)
  3. Anshul Maheshwari (CFO)
  4. Michael A Pisetsky (SVP)
  5. John Gordon Freund (Director)
  6. Jeffrey W Dunn (Director)
  7. Timothy E Davis Jr (Director)
  8. Mika Nishimura (Director)
  9. Jeryl L Hilleman (Director)
Learn More about top insider investors at SI-BONE.

Who are the major institutional investors of SI-BONE?

SI-BONE's top institutional shareholders include:
  1. Vanguard Group Inc. — 5.74%
  2. American Century Companies Inc. — 5.67%
  3. Geode Capital Management LLC — 2.23%
  4. Harbor Capital Advisors Inc. — 2.01%
  5. Impax Asset Management Group plc — 1.83%
  6. Wellington Management Group LLP — 1.20%
Learn More about top institutional investors of SI-BONE stock.

Which institutional investors are selling SI-BONE stock?

Within the previous quarter, SIBN stock was sold by these institutional investors:
  1. Wellington Management Group LLP
  2. Victory Capital Management Inc.
  3. New York State Common Retirement Fund
  4. Vanguard Group Inc.
  5. SG Americas Securities LLC
  6. Corebridge Financial Inc.
  7. Bank of New York Mellon Corp
During the last year, company insiders that have sold SI-BONE company stock include:
  1. Laura Francis (CEO)
  2. Anthony J Recupero (Insider)
  3. Anshul Maheshwari (CFO)
  4. Michael A Pisetsky (SVP)
  5. John Gordon Freund (Director)
Learn More investors selling SI-BONE stock.

Which institutional investors are buying SI-BONE stock?

Within the last quarter, SIBN stock was acquired by institutional investors including:
  1. American Century Companies Inc.
  2. Harbor Capital Advisors Inc.
  3. First Eagle Investment Management LLC
  4. Tocqueville Asset Management L.P.
  5. JPMorgan Chase & Co.
  6. Raymond James Financial Inc.
  7. Trexquant Investment LP
  8. Essex Investment Management Co. LLC